The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
898747636 8987476 36 F 201206 20160805 20121227 20160809 EXP CA-ROCHE-1130239 ROCHE 65.57 YR F Y 84.00000 KG 20160809 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
898747636 8987476 1 PS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) LAST DOSE ON 15/SEP/2015. U B20051,B20121,B10081,B20141,B20091, 125276 728 MG SOLUTION FOR INFUSION
898747636 8987476 2 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) U B20051,B20121,B10081,B20141,B20091, 125276 727 MG SOLUTION FOR INFUSION
898747636 8987476 3 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) U B20051,B20121,B10081,B20141,B20091, 125276 725 MG SOLUTION FOR INFUSION
898747636 8987476 4 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) U B20051,B20121,B10081,B20141,B20091, 125276 727 MG SOLUTION FOR INFUSION
898747636 8987476 5 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) U B20051,B20121,B10081,B20141,B20091, 125276 SOLUTION FOR INFUSION
898747636 8987476 6 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) U B20051,B20121,B10081,B20141,B20091, 125276 SOLUTION FOR INFUSION
898747636 8987476 7 SS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) 103705 1000 MG SOLUTION FOR INFUSION
898747636 8987476 8 SS ACTEMRA TOCILIZUMAB 1 Subcutaneous 125472 162 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE /wk
898747636 8987476 9 SS PRAVASTATIN. PRAVASTATIN 1 Unknown 0 20 MG
898747636 8987476 10 SS PRAVASTATIN. PRAVASTATIN 1 Unknown 0 40 MG
898747636 8987476 11 C ASPIRIN. ASPIRIN 1 0
898747636 8987476 12 C LOSEC OMEPRAZOLE 1 0
898747636 8987476 13 C VASOTEC (CANADA) 2 0
898747636 8987476 14 C BLOCADREN TIMOLOL MALEATE 1 0
898747636 8987476 15 C XANAX ALPRAZOLAM 1 0
898747636 8987476 16 C METHOTREXATE. METHOTREXATE 1 0
898747636 8987476 17 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 0
898747636 8987476 18 C FOLIC ACID. FOLIC ACID 1 0
898747636 8987476 19 C OMEGA 3 OMEGA-3 FATTY ACIDS 1 0
898747636 8987476 20 C TYLENOL ARTHRITIS PAIN ACETAMINOPHEN 1 Oral 0 650 MG
898747636 8987476 21 C BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 Oral 0 50 MG
898747636 8987476 22 C SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) 0 100 MG
898747636 8987476 23 C ACETYLSALICYLIC ACID ASPIRIN 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
898747636 8987476 1 Rheumatoid arthritis
898747636 8987476 7 Rheumatoid arthritis
898747636 8987476 8 Rheumatoid arthritis
898747636 8987476 9 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
898747636 8987476 OT
898747636 8987476 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
898747636 8987476 Abdominal mass
898747636 8987476 Abdominal pain
898747636 8987476 Arthralgia
898747636 8987476 Arthritis
898747636 8987476 Back pain
898747636 8987476 Bite
898747636 8987476 Blindness unilateral
898747636 8987476 Blood pressure increased
898747636 8987476 Blood urine present
898747636 8987476 Bronchitis
898747636 8987476 Clostridium difficile colitis
898747636 8987476 Cough
898747636 8987476 Dyspnoea
898747636 8987476 Dysuria
898747636 8987476 Ear infection
898747636 8987476 Eye infection
898747636 8987476 Furuncle
898747636 8987476 Heart rate decreased
898747636 8987476 Heart valve incompetence
898747636 8987476 Herpes zoster
898747636 8987476 Hypotension
898747636 8987476 Infusion related reaction
898747636 8987476 Injection site haematoma
898747636 8987476 Lung infection
898747636 8987476 Oxygen saturation decreased
898747636 8987476 Peripheral swelling
898747636 8987476 Pneumonia
898747636 8987476 Pulmonary oedema
898747636 8987476 Sinusitis
898747636 8987476 Throat irritation
898747636 8987476 Urinary tract infection
898747636 8987476 Weight decreased
898747636 8987476 Weight increased
898747636 8987476 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
898747636 8987476 1 20110519 20120618 0
898747636 8987476 2 20121221 0
898747636 8987476 3 20130122 0
898747636 8987476 4 20130319 0
898747636 8987476 5 20140725 0
898747636 8987476 6 20141022 0
898747636 8987476 7 20100907 20100921 0
898747636 8987476 8 20160614 0
898747636 8987476 20 20100907 20100921 0
898747636 8987476 21 20100907 20100921 0
898747636 8987476 22 20100907 20100921 0